InSphero
Provides 3D microtissues used for more PREdictive drug screening
Total raised
€22M
€21,636,362
Funding rounds
3
Investors
1
distinct backers
Active since
2010-07
latest 2015-06
Funding by year
EUR raised per yearSignals
Medium confidenceRaise-next likelihood23
base rate 51% for Series C
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
Exit likelihood16
base rate 12% (2+ rounds)
- ▲ 3 rounds raised
- ▲ 17y since founding
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2015-07-01 | Series C | €18M | — | View deal → |
| 2013-06-01 | Series B | €1.9M | — | View deal → |
| 2010-08-01 | Series A | €1.5M | Redalpine | View deal → |
Investors
1Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Climeworks€920MSwitzerland · Cleantech
- Energy Vault€896MSwitzerland · Energy